QID 242243

Date Published: 2023-10-25

QID 242243: Red Hat Update for python39:3.9 and python39-devel:3.9 (RHSA-2023:6069)

Python is an interpreted, interactive, object-oriented programming language, which includes modules, classes, exceptions, very high level dynamic data types and dynamic typing.
Python supports interfaces to many system calls and libraries, as well as to various windowing systems...Security Fix(es):

    python: tls handshake bypass (cve-2023-40217).
<H2></H2>
    Red Hat enterprise linux server - aus 8.4 x86_64.
    Red hat enterprise linux server - tus 8.4 x86_64.
    Red hat enterprise linux server for power le - update services for sap solutions 8.4 ppc64le.
    Red hat enterprise linux for x86_64 - update services for sap solutions 8.4 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Medium - 5.3 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:6069 for updates and patch information.
    Vendor References

    CVEs related to QID 242243

    CVE-2023-40217 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:6069 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:6069
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].